Impact of metformin on the progression of MGUS to multiple myeloma

May-17

AUTHORS : Dr Brendan M. Weiss, M.D., Abramson Cancer Center, University of Pennsylvania, Perelman Center for Advanced Medicine – 2 West, 3400 Civic Center Boulevard, Philadelphia, PA, 19104 (Janssen Research & Development, LLC, 1400 McKean Road, P.O. Box 776, Spring House, PA 19477 on profile website)- Email: brendan.weiss@uphs.upenn.edu – Profile: https://www.med.upenn.edu/apps/faculty/index.php/g5455356/p8478251

JOURNAL : Leukemia & Lymphoma

REFERENCE: 58(5):1265-1267

DOI : 10.1080/10428194.2016.1236375

Impact of metformin on the progression of MGUS to multiple myeloma

More publications

Evaluating the potential impact of lifestyle‑based behavior change interventions delivered at the time of colorectal cancer screening

Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions

Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin